[The distribution of ventilation and perfusion in the obstructive syndrome during nitroglycerin and bronchospasmolytic therapy].
In chronic obstructive lung disease and pulmonary artery hypertension a cranialisation of both ventilation and perfusion can be observed. Nitroglycerine induces a decrease of tension and peripheral resistance. A ventilation-perfusion mismatching induces arterial hypoxemia. If bronchospasmolytic agents are added, hypoxemia can be prohibited.
D000368:Aged; D005280:Fenoterol / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000503:physiopathology*; D000860:Hypoxia / Q000517:prevention & control; D008168:Lung / Q000503:physiopathology; D008173:Lung Diseases, Obstructive / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use*; D014018:Tissue Distribution
D005280:Fenoterol; D005996:Nitroglycerin
Die Verteilung von Ventilation und Perfusion beim obstruktiven Syndrom unter Nitroglyzerin und gleichzeitiger bronchospasmolytischer Therapie.